Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection [Phase 3]
A Phase 3 trial evaluating BIO-K+ CL1285 for prevention of recurrent Clostridioides difficile infection has been suspended, with no results …
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Mucosal Versus Fecal Microbiota in FMT
A completed clinical trial comparing mucosal versus fecal microbiota approaches in fecal microbiota transplantation for Clostridioides diffi…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Probiotics for Clostridium Difficile Infection in Older Adults [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating probiotics for Clostridioides difficile infection in older adults.
-
CLINICAL_TRIALS withdrawal · 2015-10-27Clinical Trial Update: UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients
A non-interventional observational trial (NCT01622595) evaluating infectious complications in cancer patients sponsored by the University of…
-
CLINICAL_TRIALS research · 2015-10-01Clinical Trial Update: Fecal Transplant for Relapsing C. Difficile Infection [Phase 2]
Phase 2 clinical trial update evaluating fecal microbiota transplantation for relapsing Clostridioides difficile infection. No trial results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-09-23Clinical Trial Update: Gut Microbiota Changes After Fecal Microbiota Transplantation [Phase 2]
Clinical trial update describing gut microbiota changes after fecal microbiota transplantation in Clostridioides difficile infection. The st…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis
A completed clinical trial compared vancomycin with nitazoxanide for recurrent Clostridioides difficile infection (C. difficile colitis).
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease [Phase 3]
Phase 3 study of nitazoxanide for the treatment of Clostridioides difficile infection has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis [NA]
This clinical trial update reports the termination of a study evaluating optimal surgical treatment for fulminant Clostridioides difficile i…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea [Phase 2]
A Phase 2 study evaluating the absorption of GT267-004 in patients with Clostridioides difficile infection-associated diarrhea has completed…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea [Phase 3]
Phase 3 trial of Exodif for Clostridioides difficile infection-associated diarrhea was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea [Phase 2]
Phase 2 trial comparing GT160-246 to vancomycin in patients with Clostridioides difficile infection has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea [Phase 3]
Phase 3 study comparing GT267-004 to vancomycin and to metronidazole in patients with Clostridioides difficile infection (C. difficile-assoc…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis
Astellas-sponsored trial evaluating fidaxomicin in neonates to assess Clostridioides difficile involvement has been terminated.
-
FDA approval · 2015-02-24FDA Approved: DIFICID — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for DIFICID (fidaxomicin) from Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Reduction of C-Difficile Infection Using Stool Transplant [Phase 1]
Phase 1 trial investigating fecal microbiota transplantation to reduce Clostridioides difficile infection.
-
CLINICAL_TRIALS research · 2014-12-30Clinical Trial Update: Clostridium Difficile Infection: the First Report in Southeast Asia by 2010 Nationwide Study
A nationwide study completed by 2010 provides the first report of Clostridioides difficile infection in Southeast Asia.
-
CLINICAL_TRIALS withdrawal · 2014-12-08Clinical Trial Update: Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin [Phase 2, Phase 3]
A Phase 2/3 trial comparing oral vancomycin followed by fecal microbiota transplantation versus tapering oral vancomycin was terminated.
-
CLINICAL_TRIALS withdrawal · 2014-11-18Clinical Trial Update: Probiotics in Hospitalized Patients Study [NA]
A clinical trial evaluating probiotics for antibiotic-associated diarrhea and Clostridioides difficile infection in hospitalized patients wa…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84 [Phase 1]
An open-label Phase 1 study assessing the safety, immunogenicity and dose response of IC84 in Clostridioides difficile infection; the trial …
-
CLINICAL_TRIALS research · 2014-09-11Clinical Trial Update: Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection [Phase 4]
Phase 4 clinical trial update evaluating vancomycin prophylaxis to prevent recurrent Clostridioides difficile infection.
-
CLINICAL_TRIALS research · 2014-08-20Clinical Trial Update: The Impact of Proton Pump Inhibitors on the Fecal Microbiome [Phase 1]
Phase 1 clinical trial, sponsored by Mayo Clinic, investigates how proton pump inhibitors affect the fecal microbiome, including healthy vol…
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of BIO-K plus CL1285 for preventing antibiotic-associated diarrhea in hospitalized adults…
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum [Phase 1]
Phase 1 trial evaluating safety and tolerability of a frozen-inoculum fecal microbiota transplant for relapsing Clostridioides difficile inf…
-
CLINICAL_TRIALS withdrawal · 2014-05-28Clinical Trial Update: Fidaxomicin to Prevent Clostridium Difficile Colonization [Phase 4]
Phase 4 trial of fidaxomicin to prevent Clostridioides difficile infection has been withdrawn.